After expanding in August 2024 to include lower-cost single-use vials of Zepbound (tirzepatide) for self-pay patients, Lilly reported that by mid-2025 approximately one-third of new Zepbound prescriptions were being filled through the platform signaling that DTP had become a meaningful access channel rather than a niche experiment
Ribeiro-Silva, J
If you have objections to copyrighted content or material made available on or through our Sites, you may submit a notification to our Designated Agent at the following address: [email protected] Any notification to Brightmeds LLC under 17 U.S.C
In case of mutations affecting the function of the bile salt transporter, but especially when the FGF19-driven negative feedback pathway is defective, this leads to bile acid diarrhea type 2 (168)
Merkel M, Weinstock PH, Chajek-Shaul T, Radner H, Yin B, Breslow JL, et al
Once approved, log in and click Card in the top navigation